Universe Pharmaceuticals (UPC) Receivables: 2020-2024
- Universe Pharmaceuticals' Receivables rose 44.63% to $18.7 million in Q3 2024 from the same period last year, while for Sep 2024 it was $63.5 million, marking a year-over-year decrease of 3.14%. This contributed to the annual value of $18.7 million for FY2024, which is 44.63% up from last year.
- Per Universe Pharmaceuticals' latest filing, its Receivables stood at $18.7 million for Q3 2024, which was up 30.06% from $14.4 million recorded in Q1 2024.
- In the past 5 years, Universe Pharmaceuticals' Receivables registered a high of $19.2 million during Q1 2022, and its lowest value of $11.5 million during Q3 2020.
- In the last 3 years, Universe Pharmaceuticals' Receivables had a median value of $16.7 million in 2022 and averaged $16.4 million.
- Per our database at Business Quant, Universe Pharmaceuticals' Receivables decreased by 19.03% in 2023 and then surged by 44.63% in 2024.
- Quarterly analysis of 5 years shows Universe Pharmaceuticals' Receivables stood at $11.5 million in 2020, then spiked by 41.22% to $16.3 million in 2021, then fell by 1.73% to $16.0 million in 2022, then declined by 19.03% to $12.9 million in 2023, then skyrocketed by 44.63% to $18.7 million in 2024.
- Its last three reported values are $18.7 million in Q3 2024, $14.4 million for Q1 2024, and $12.9 million during Q3 2023.
